
BLBD vs RIVN

In the past 12 months, BLBD returned +73% while RIVN gained 9%.
Valuation
Compare price multiples and valuation ratios
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | 16.15 | -5.79 | RIVN |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 1.44 | 3.71 | BLBD |
P/B Ratio Price to book ratio | 7.21 | 4.62 | RIVN |
P/FCF Ratio Price to free cash flow ratio | 11.67 | -8.23 | RIVN |
EV/EBITDA Enterprise value to EBITDA | 9.87 | -7.66 | RIVN |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 21.0% | -1.7% | BLBD |
Operating Margin Operating profit margin | 11.9% | -68.9% | BLBD |
Net Margin Net profit margin | 8.9% | -63.6% | BLBD |
ROE Return on equity | 50.8% | -70.0% | BLBD |
ROA Return on assets | 19.3% | -24.7% | BLBD |
ROIC Return on invested capital | 30.2% | -30.6% | BLBD |
Growth
Compare revenue and earnings growth rates
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | 9.9% | 8.4% | BLBD |
Revenue Growth (3Y) 3-year revenue CAGR | 22.7% | 48.1% | RIVN |
Revenue Growth (5Y) 5-year revenue CAGR | 11.0% | 0.0% | BLBD |
EPS Growth (YoY) Year-over-year EPS growth | 22.8% | 34.5% | RIVN |
EPS Growth (3Y) 3-year EPS CAGR | 0.0% | 0.0% | Tie |
EPS Growth (5Y) 5-year EPS CAGR | 63.7% | 0.0% | BLBD |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 0.30 | 1.49 | BLBD |
Current Ratio Current assets to current liabilities | 1.83 | 2.10 | RIVN |
Quick Ratio Quick assets to current liabilities | 1.27 | 1.64 | RIVN |
Interest Coverage EBIT to interest expense | 26.91 | -27.82 | BLBD |
Beta Stock volatility vs market | 1.37 | 1.65 | BLBD |
7211.T
LCID
NFI.TO